Switch to:
More From Other Websites
Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent Jun 29 2015
Biotech Short-Sellers Prefer Amgen To Gilead Sciences Jun 27 2015
Five Best Stocks to Buy According To Quant Billionaires Jun 25 2015
The Zacks Analyst Blog Highlights: BioMarin, Vical, Epizyme, Amgen and Medicines Co - Press Releases Jun 25 2015
Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog Jun 24 2015
Inside Kite Pharma's 100% run Jun 24 2015
Amgen Dazzles With a Duo of Fresh Data Jun 23 2015
Amgen Presents Interim Data on Migraine Drug AMG 334 - Analyst Blog Jun 22 2015
Celimmune to Present Experimental Anti-IL-15 Antibody AMG 714 at 16th International Coeliac Disease... Jun 22 2015
Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of... Jun 19 2015
Amgen Cancer Drug Vectibix Hits Phase III Primary Endpoint - Analyst Blog Jun 19 2015
Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of... Jun 19 2015
Biotech bargain bin Jun 19 2015
Biotechs about to break out: Pro Jun 19 2015
Healthcare heats up in the summer Jun 19 2015
Early movers: HSY, RHT, SWHC, STT, CAG & more Jun 19 2015
How Much Should Cancer Drugs Cost? Jun 18 2015
Amgen's cancer drug meets main goal in late-stage study Jun 18 2015
Biotech's big boost Jun 18 2015
Amgen cancer drug meets testing goal Jun 18 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK